News | Heart Failure | August 09, 2016

Higher ICU Usage for Heart Failure, PE Led to Increased Invasive Procedures and Costs

Study of four common conditions finds intensive care unit use did not improve mortality rates

ICU use for heart failure

August 9, 2016 – With the use of intensive care units (ICUs) on the rise in many hospitals, researchers at LA BioMed and University of California, Los Angeles (UCLA) examined ICU usage and found patients who were admitted to these units underwent more costly and invasive procedures, but didn’t have better mortality rates than hospitalized patients with the same medical conditions who were not admitted to the ICU.
 
The study, published online in JAMA Internal Medicine, examined records from 156,842 hospitalizations at 94 acute care hospitals for four medical conditions where ICU care is frequently provided, but may not be medically necessary: congestive heart failure, diabetic ketoacidosis, pulmonary embolism, and upper gastrointestinal hemorrhage.

The study found the hospitals that utilize ICUs more frequently were more likely to perform invasive procedures and incur higher costs. But the study found these hospitals had no improvement in mortality among patients in the ICU when compared with other hospitalized patients with these four conditions.
 
“The study findings suggest that optimizing the value of ICU care will require assessments of systematic institutional factors that may lead clinicians to over-utilize ICU care,” said Dong W. Chang, M.D., an LA BioMed researcher and corresponding author of the study. “In addition, overuse of ICUs among patients who can likely be treated in non-ICU settings may lead to inappropriately aggressive care and misallocation of resources away from patients who may truly need critical care services.”

The researchers reported that smaller hospitals and teaching hospitals used ICUs at higher rates for patients with the four conditions studied that did larger hospitals. The difference in the average costs ranged from $647 more for upper gastrointestinal hemorrhage care in the ICU, to $3,412 more to care for a patient with congestive heart failure in the ICU, when compared with hospital care for the same conditions outside the ICU.

“This study begins to tell the story of how the inappropriate use of ICUs can be harmful for patients and costly for the healthcare system,” said Chang. “But the story is incomplete, and we need more information on the mechanisms that drive some hospitals to use their ICUs more readily. In the meantime, hospital policies and institutional protocols in non-ICU settings that lead to overutilization of ICU care should be examined because they represent the best opportunities for reducing invasive procedures and lowering costs while ensuring the best possible care for the patient.”
 
Martin F. Shapiro, M.D., Ph.D., from the David Geffen School of Medicine at UCLA, was the other researcher for the study. The study was supported by the NIH/National Center for Advancing Translational Science (NCATS) UCLA CTSI Grant Number UL1TR000124. 

For more information: http://archinte.jamanetwork.com/multimedia.aspx.

Related Content

Heart Failure Market to Surpass $16 Billion by 2026
News | Heart Failure| September 19, 2017
The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain, the U.K. and Japan is...
Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study in Denmark

Vascular screening for abdominal aortic aneurysm, peripheral artery disease and hypertension during the VIVA Study. Photo credit: Lisbeth Hasager Justesen, Viborg Hospital.

News | Cardiac Diagnostics| September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, accordin
Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO). CRF sponsors TCT.

The Cardiovascular Research Foundation (CRF) announced the promotion of Juan F. Granada, M.D., as the foundation’s president and chief executive officer (CEO).

Feature | Cath Lab| September 12, 2017
September 12, 2017 – The Cardiovascular Research Foundation (CRF) a
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Israeli Hospital Completes First Implant of CORolla Heart Failure Device
News | Heart Failure| September 05, 2017
Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli start-up company...
Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD)| August 29, 2017
Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left...
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Sponsored Content | Videos | Cardiovascular Ultrasound| August 28, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
News | August 28, 2017
To ensure you continue to receive information most critical to your job, please participate in a survey that will tak
Overlay Init